TFC Financial Management’s Sage Therapeutics SAGE Stock Holding History

TFC Financial Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100	Closed	-$912	–	1047
2025 Q2	$912	Hold	100	–	–	﹤0.01%	586
2025 Q1	$795	Hold	100	–	–	﹤0.01%	584
2024 Q4	$543	Hold	100	–	–	﹤0.01%	643
2024 Q3	$722	Sell	100 -1	-1%	-$9	﹤0.01%	620
2024 Q2	$1.1K	Buy	+101	New	+$1.29K	﹤0.01%	553

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

TFC Financial Management's SAGE Position: Q3 2025 in Review

TFC Financial Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 100 shares — an estimated $912 sold.

TFC Financial Management first reported a position in SAGE in Q2 2024 and held it in 5 quarters. The position peaked at $1.1K in Q2 2024. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

TFC Financial Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
TFC Financial Management sold 100 Sage Therapeutics shares in Q3 2025, an estimated $912.
TFC Financial Management first reported a position in Sage Therapeutics in Q2 2024 and held it in 5 quarters.
TFC Financial Management's Sage Therapeutics position peaked at $1.1K in Q2 2024.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on TFC Financial Management's 13F filing for Q3 2025, filed 24 Oct 2025.